OTC

Flonase teams up with Major League Baseball and World Series champion Cody Bellinger to change the game on allergy season

WARREN, N.J., April 1, 2021 /PRNewswire/ -- GSK Consumer Healthcare (LSE/NYSE: GSK) announced today that Flonase Allergy Relief (Flonase) is partnering with World Series champion and seasonal allergy-sufferer Cody Bellinger of the Los Angeles Dodgers as the new face of the brand's "Change The Game" campaign. The commitment is part of a larger partnership with Major League Baseball (MLB), recognizing Flonase as the Official Allergy Relief Partner of MLB. Continue Reading ™/© 2021 MLB ™/© 2021 MLB "Baseball is a game that requires extreme focus, but unfortunately the field is full of

Sports Stocks Approach Breakout Potential (OTC US: BTDG) ($CHDN) ($WWE) ($MSGS)

The live sports space has been a key story in the process of the pandemic. Now, with multiple vaccine candidates moving toward emergency use authorization, that reality is heightened. Normality is nearing a return. In the past three weeks, we have seen COVID-19 vaccine candidates from Pfizer/BioNtech, Moderna, and Oxford/AstraZeneca all report strong data and promising safety/efficacy profiles, which shapes the market’s view and discounting mechanism powerfully. Now, we are seeing new announcements from both Russia and China ringing the same bell. The reopening trade is on in a big